HMCTF yields 165.29% · PFE yields 6.13%● Live data
📍 HMCTF pulled ahead of the other in Year 1
Combined, HMCTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HMCTF + PFE for your $10,000?
Hainan Meilan International Airport Company Limited, together with its subsidiaries, engages in the aeronautical and non-aeronautical businesses at the Haikou Meilan International Airport in Haikou, the People's Republic of China. Its aeronautical business includes the provision of terminal facilities, ground handling services, and passenger services. The company's non-aeronautical business comprises the leasing of commercial and retail spaces at Haikou Meilan International Airport; franchise of airport-related business; leasing of advertising space; provision of car parking and cargo handling services; and sale of consumable goods. It is also involved in the business investment, and hotel investment and operation activities; and rendering of cargo and logistics services. The company was formerly known as Regal International Airport Group Company Limited and changed its name to Hainan Meilan International Airport Company Limited in November 2019. The company was incorporated in 2000 and is headquartered in Haikou, the People's Republic of China. Hainan Meilan International Airport Company Limited is a subsidiary of Haikou Meilan International Airport Company Limited.
Full HMCTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.